Metabolism, Inborn Errors

15 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Metabolism, Inborn Errors
Treatment and conditionWhere it standsTrials
BBI-001 for hemochromatosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
BEAM-301: Single dose of BEAM-301 administered by IV for glycogen storage disease type iPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for homozygous familial hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for hyperlipoproteinemia type vPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Efzimfotase Alfa for hypophosphatasiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide Decanoate for hyperlipoproteinemia type iiPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
mRNA-3927 for propionic acidemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Olezarsen for hyperlipoproteinemia type iPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Osilodrostat for adrenal hyperplasia, congenitalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 1 Dose Level 1 + Phase 1 Dose Level 2 + Phase 1 Dose Level 3 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Established Dose from prior study, NCT03810196 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Maximum Tolerated Dose determined in Phase 1 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
RP-A501 for lysosomal storage diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
SHR-1918 for homozygous familial hypercholesterolemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for hyperlipoproteinemia type iiPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1